The maternal care brand enters a new chapter as longtime CEO Kevin Vyse-Peacock steps down and North America president Julie Talbot takes the helm amid global expansion.
Lansinoh has announced a planned leadership transition, naming Julie Talbot as Global Chief Executive Officer effective April 1, 2026. She succeeds Kevin Vyse-Peacock, who is stepping away after 25 years with the maternal care company, including 15 years as CEO.
Vyse-Peacock joined Lansinoh in 2001 to establish its European operations and later guided the brand through significant international growth. During his tenure, the company expanded from a smaller, single-product focus into a broader portfolio serving parents in more than 60 countries. Lansinoh reports that business growth increased substantially under his leadership, alongside efforts to position the brand as science-led and mission-driven.
Leadership changes of this scale often mark more than a personnel shift; they signal evolving priorities. Lansinoh operates in a category shaped by changing attitudes toward breastfeeding, parental leave, and maternal health support. As consumer expectations shift toward more holistic and accessible care, companies in this space face pressure to modernize while maintaining credibility and trust.
Talbot, who currently serves as President of North America, has been involved in refining the brand’s positioning and expanding investment in innovation. She also oversaw the move to bring consumer care operations in-house, building a support model that includes certified lactation counselors. Her appointment suggests continuity in mission, paired with an emphasis on brand modernization and global alignment.
The transition also reflects broader generational shifts in leadership within purpose-driven consumer brands. Vyse-Peacock has indicated plans to focus on mentoring and supporting other mission-led businesses, while Talbot steps into a role that blends operational strategy with an increasingly visible public voice for the company.
For Lansinoh, the change comes at a moment when maternal health conversations are more prominent globally. As the company moves into its next phase, the challenge will be balancing growth with the empathy and trust that have defined its identity for more than four decades.
